Advertisement
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
694 dias atrás
Japan GDP Data Due On Friday
Japan will on Friday release preliminary Q1 numbers for gross domestic product, highlighting a modest day for Asia-Pacific economic activity. GDP is expected to slip 0.1 percent on quarter and 0.2 percent on year after adding 0.6 percent on quarter and 2.2 percent on year in the three month prior.
RTTNews
|
5 minutos atrás
South Korea Export Prices Rise 0.7% On Year In April
Export prices in South Korea were up 0.7 percent on year in April, the Bank of Korea said on Friday, easing from 6.3 percent in March.
RTTNews
|
54 minutos atrás
Euro Drops Against Majors
The euro weakened against its major counterparts in the New York session on Thursday.
RTTNews
|
2h 43min atrás
Swiss Market Shrugs Off Weak Start, Ends On Firm Note
After opening weak and remaining subdued till noon, Swiss stocks found some support and kept edging higher on Thursday, and finally ended the day's session on a firm note.
Data showing a strong pace of expansion of the Swiss economy in the first quarter of this year aided sentiment.
RTTNews
|
4h 26min atrás
Major European Markets Recover After Early Setback, Close On Firm Note
Despite an early struggle, the major European markets turned in fairly steady performance as the session progressed on Thursday to eventually close on a firm note. Easing concerns about tariffs and U.S. inflation, and some encouraging regional economic data helped underpin sentiment.
RTTNews
|
4h 44min atrás
U.S. Business Inventories Inch Up Slightly Less Than Expected In March
The Commerce Department released a report on Thursday showing a slight increase by U.S. business inventories in the month of March. The report said business inventories crept up by 0.1 percent in March after rising by 0.2 percent in February. Economists had expected business inventories to rise by another 0.2 percent.
RTTNews
|
5h 58min atrás
TSX Rises For 8th Straight Session, Looks Set To Scale New Peak
The Canadian market is up in positive territory, extending gains to an eighth straight session, as the undertone continues to remain firm amid easing concerns about tariffs, and the recent data showing a smaller than expected increase in U.S. consumer price inflation in the month of April.
RTTNews
|
6h 3min atrás
